Search

Displaying 81 - 90 of 14331
Drupal spam blocked by CleanTalk.
Author year
Species-Specific Differences in the Susceptibility of Fungi to the Antifungal Protein AFP Depend on C-3 Saturation of Glycosylceramides. Paege N, Warnecke D, Zäuner S, Hagen S, Rodrigues A, Baumann B, Thiess M, Jung S, Meyer V. 2019
Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India. Halder R, Seth T, Chaturvedi PK, Mishra P, Mahapatra M, Pati HP, Tyagi S, Saxena R. 2020
Role of recombinant Aspergillus fumigatus antigens in diagnosing Aspergillus sensitization among asthmatics. Muthu V, Singh P, Choudhary H, Dhooria S, Sehgal IS, Prasad KT, Aggarwal AN, Garg M, Chakrabarti A, Agarwal R. 2020
Open-Label Crossover Oral Bioequivalence PK Comparison for a 3-Day Loading Dose Regimen and 15-Day Steady-State Administration of SUBA™-Itraconazole and Conventional Itraconazole Capsules in Healthy Adults. Thompson GR 3rd, Lewis P, Mudge S, Patterson TF, Burnett BP. 2020
Antifungal itraconazole ameliorates experimental autoimmune encephalomyelitis through a novel mechanism of action. Huang H, Tian X, Peng X, Huang L, Mei L, Zhan Y, Chen S, Wu H, Wei G, Cai X. 2020
Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients. Lehrnbecher T, Fisher BT, Phillips B, Beauchemin M, Carlesse F, Castagnola E, Duong N, Dupuis LL, Fioravantti V, Groll AH, Haeusler GM, Roilides E, Science M, Steinbach WJ, Tissing W, Warris A, Patel P, Robinson PD, Sung L. 2020
Pharmacokinetic Drug Interactions of an Orally Available TRH Analog (Rovatirelin) With a CYP3A4/5 and P-Glycoprotein Inhibitor (Itraconazole). Kobayashi K, Abe Y, Kawai A, Furihata T, Endo T, Takeda H. 2020
Oral absorption of voriconazole is affected by SLCO2B1 c.*396T>C genetic polymorphism in CYP2C19 poor metabolizers. Lee SW, Oh J, Kim AH, Ji SC, Park SI, Yoon SH, Chung JY, Yu KS, Jang IJ, Lee S. 2020
Improvement of the pharmacokinetic/pharmacodynamic relationship in the treatment of invasive aspergillosis with voriconazole. Reduced drug toxicity through novel rapid release formulations. Gallego-Arranz T, Pérez-Cantero A, Torrado-Salmerón C, Guarnizo-Herrero V, Capilla J, Torrado-Durán S. 2020
Advances in Molecular Tools and In Vivo Models for the Study of Human Fungal Pathogenesis. Malavia D, Gow NAR, Usher J. 2020

Pages

Subscribe to Search